Alfredo Papa

30PUBLICATIONS
117CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMicrobial ecologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 28, 2026
Rewriting Inflammation in IBD: Lipidomics from Pathogenesis to Clinical Application.

|Jul 23, 2026
Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study.

|Jul 15, 2026
Endothelial VEGFR-2 Activation Precedes Severe Mucosal Injury in TNBS-Induced Colitis.

|May 27, 2026
Emerging Role of Gut Microbiota in Modulating Response to Therapies in IBD.

|May 09, 2026
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study.

|May 05, 2026
The DICA endoscopic score and the CODA clinical score may predict the severity of acute diverticulitis and the risk of hospitalisation: results from an international multicentre prospective cohort study.

Pageof 5

Frequent Collaborators

15 joint publications

Franco Scaldaferri

10 joint publications

Antonio Tursi

9 joint publications

Loris Riccardo Lopetuso

9 joint publications

Antonio Gasbarrini